Peter J. Greasley

107 papers receiving 5.7k citations

Peter J. Greasley's Hit Papers

Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial 2023 · 71 citations
710+6+12Years since publication4008001.2k

Peers

Peter J. Greasley
Comparison fields: 5 of 155
  • Pharmacology 2.8k
  • Endocrinology, Diabetes and Metabolism 1.6k
  • Cellular and Molecular Neuroscience 1.5k
  • Toxicology 213
  • Nephrology 430
Replace Jonathan Z. Long with:
Jonathan Z. Long United States
Simon D Harding United Kingdom
Elizabeth A. Thiele United States
Jean‐Pierre Maffrand France
Yedy Israel Canada
Hannu Alho Finland
Michael C. Irizarry United States
Luca Pani Italy
Susumu Higuchi Japan
John A. Peters United Kingdom
Peter J. Greasley relative to Jonathan Z. Long United States Jonathan Z. Long's profile →
Citations per field
00.5×9.6×
Jonathan Z. Long · 1×
Citations per year

Countries citing papers authored by Peter J. Greasley

Since Specialization
Citations

This map shows the geographic impact of Peter J. Greasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Greasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Greasley more than expected).

Fields of papers citing papers by Peter J. Greasley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Greasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Greasley. The network helps show where Peter J. Greasley may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter J. Greasley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. Greasley Line = papers co-authored together Peter J. Greasley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#Work
1
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
Hit paper breakdown →
20101284
2
The orphan receptor GPR55 is a novel cannabinoid receptor
Hit paper breakdown →
20071249
3
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis
Hit paper breakdown →
2017355
4 2009258
5 2009214
6 2020180
7 2017115
8 2004109
9 2000108
10 2001106
11 200299
12 202087
13 201979
14 201874
15
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
Hit paper breakdown →
202371
16 200171
17 200756
18 201851
19 201148
20 201247

About Peter J. Greasley

Peter J. Greasley is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Nephrology, Surgery and Cardiology and Cardiovascular Medicine, having authored 113 papers that have together received 5.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (36 papers), Chronic Kidney Disease and Diabetes (23 papers), Pancreatic function and diabetes (21 papers), Cannabis and Cannabinoid Research (12 papers), Receptor Mechanisms and Signaling (10 papers), Phytase and its Applications (9 papers), Cardiovascular Function and Risk Factors (7 papers) and Renal Diseases and Glomerulopathies (6 papers). The work is most often cited by research in Pharmacology (2.8k citations), Endocrinology, Diabetes and Metabolism (1.6k citations), Cellular and Molecular Neuroscience (1.5k citations), Toxicology (213 citations) and Nephrology (430 citations). Peter J. Greasley has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Erik Ryberg, Thomas Elebring, Stephan Hjorth, Ken Mackie, Ruth A. Ross, Niklas Larsson, S. Sjögren, Peter Nilsson, Nils-Olov Hermansson and Tomáš Drmota. Their work appears in journals such as Diabetes Obesity and Metabolism, Nephrology Dialysis Transplantation, FEBS Letters, Biochemical Journal and Clinical Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact